(Circulation. 2001;103:363.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery
From the Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio (D.L.B., D.P.C., E.J.T.); Vascular Medicine Program, University of Minnesota Medical School, Minneapolis (A.T.H); and Department of Neurology, University of Heidelberg Medical School, Heidelberg, Germany (P.A.R., W.H.).
Correspondence to Eric J. Topol, MD, Department of Cardiology, F25, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, Ohio 44195. E-mail topole{at}ccf.org
Background—After coronary artery bypass surgery, patients have a high cumulative rate of graft closure and recurrent ischemic events. We sought to determine whether antiplatelet therapy with clopidogrel would be more effective than aspirin, the accepted standard, in these patients.
Methods and Results—The event rates for all-cause mortality, vascular death, myocardial infarction, stroke, and rehospitalization were determined for the 1480 patients with a history of cardiac surgery randomized to either clopidogrel or aspirin in a trial of 19 185 patients. The event rate per year of vascular death, myocardial infarction, stroke, or rehospitalization was 22.3% in the 705 patients randomized to aspirin and 15.9% in the 775 patients randomized to clopidogrel (P=0.001). A risk reduction was also seen in each of the individual end points examined, including a 42.8% relative risk reduction in vascular death in patients on clopidogrel versus aspirin (P=0.030). In a multivariate model incorporating baseline clinical characteristics, clopidogrel therapy was independently associated with a decrease in vascular death, myocardial infarction, stroke, or rehospitalization in patients with a history of cardiac surgery, with a 31.2% relative risk reduction (95% CI, 15.8 to 43.8; P=0.0003). Although clopidogrel therapy was efficacious in the entire Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) population, multivariate analysis demonstrated that patients with previous cardiac surgery derived particular benefit (P=0.015).
Conclusion—Compared with aspirin, clopidogrel therapy results in a striking reduction in the elevated risk for recurrent ischemic events seen in patients with a history of prior cardiac surgery, along with a decreased risk of bleeding.
Key Words: aspirin • bypass • grafting • platelets
This article has been cited by other articles:
 |
|
 |
|
  J. M. O'Riordan, R. J. Margey, G. Blake, and P. R. O'Connell Antiplatelet Agents in the Perioperative Period Arch Surg, January 1, 2009; 144(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Talelli and R. J. Greenwood Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 387 - 405. [Abstract] [PDF]
|
|
|
|
 |
|
 L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zimmermann, E. Gams, and T. Hohlfeld Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 93 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Englberger, M. Streich, H. Tevaearai, and T. P. Carrel Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 378 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Becker, T. W. Meade, P. B. Berger, M. Ezekowitz, C. M. O'Connor, D. A. Vorchheimer, G. H. Guyatt, D. B. Mark, and R. A. Harrington The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 776S - 814S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. BAKHRU and D. L. BHATT INTERPRETING THE CHARISMA STUDY: What is the role of dual antiplatelet therapy with clopidogrel and aspirin? Cleveland Clinic Journal of Medicine, April 1, 2008; 75(4): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Badger, C. V. Soong, B. Lee, G. R. Swain, and K. E. McGuigan Prescribing Practice of General Practitioners in Northern Ireland for Peripheral Arterial Disease Angiology, March 1, 2008; 59(1): 57 - 63. [Abstract] [PDF]
|
|
|
|
 |
|
 J. K. Shim, Y. S. Choi, Y. J. Oh, S. O. Bang, K. J. Yoo, and Y. L. Kwak Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Meadows and D. L. Bhatt Clinical Aspects of Platelet Inhibitors and Thrombus Formation Circ. Res., May 11, 2007; 100(9): 1261 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow Use of Antiplatelet Drugs in Secondary Prevention in Older Persons With Atherothrombotic Disease J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 518 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. I. de Oliveira and D. L. Bhatt Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease Eur. Heart J. Suppl., October 1, 2006; 8(suppl_G): G10 - G14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Diener Update on clopidogrel and dual anti-platelet therapy: neurology Eur. Heart J. Suppl., October 1, 2006; 8(suppl_G): G15 - G19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Wang, D. L. Bhatt, and E. J. Topol Aspirin and clopidogrel resistance: an emerging clinical entity Eur. Heart J., March 2, 2006; 27(6): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Halkos, W. A. Cooper, R. Petersen, J. D. Puskas, O. M. Lattouf, J. M. Craver, and R. A. Guyton Early Administration of Clopidogrel Is Safe After Off-Pump Coronary Artery Bypass Surgery. Ann. Thorac. Surg., March 1, 2006; 81(3): 815 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Gurbuz, A. A. Zia, A. C. Vuran, H. Cui, and A. Aytac Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 190 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Poston, C. White, J. Gu, J. Brown, J. Gammie, R. N. Pierson, A. Lee, I. Connerney, T. Avari, R. Christenson, et al. Aprotinin Shows Both Hemostatic and Antithrombotic Effects During Off-Pump Coronary Artery Bypass Grafting Ann. Thorac. Surg., January 1, 2006; 81(1): 104 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kirshner, J. Biller, and A. S. Callahan III Long-Term Therapy to Prevent Stroke J Am Board Fam Med, November 1, 2005; 18(6): 528 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon, S. R. Mehta, and S. F. Aranki Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 768 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Donnelly Antiplatelet therapy and prevention of ischaemic events: CAPRIE The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 203 - 206. [PDF]
|
|
|
|
 |
|
 J. J. Saseen ASHP Therapeutic Position Statement on the Daily Use of Aspirin for Preventing Cardiovascular Events Am. J. Health Syst. Pharm., July 1, 2005; 62(13): 1398 - 1405. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Bhatt and J. Hirsh The (Variable) Definition of Benefit in the Case of Clopidogrel vs Aspirin--Reply Arch Intern Med, June 13, 2005; 165(11): 1310 - 1311. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gluckman, J. J. Rade, and S. P. Schulman The Value of Clopidogrel Administered Postoperatively Following a Non-ST-Segment Elevation Acute Coronary Syndrome Chest, June 1, 2005; 127(6): 2297 - 2297. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lansky, J. S. Hochman, P. A. Ward, G. S. Mintz, R. Fabunmi, P. B. Berger, G. New, C. L. Grines, C. G. Pietras, M. J. Kern, et al. Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women: A Statement for Healthcare Professionals From the American Heart Association Circulation, February 22, 2005; 111(7): 940 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hirsh and D. L. Bhatt Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations: Lessons From the CAPRIE and CURE Studies Arch Intern Med, October 25, 2004; 164(19): 2106 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lim, J. Cornelissen, T. Routledge, S. Kirtland, S. C. Charman, S. Bellm, H. Munday, O. Khan, I. Masood, and S. Large Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 432 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Stein, H. J. Schunemann, J. E. Dalen, and D. Gutterman Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 600S - 608S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Englberger, B. Faeh, P. A. Berdat, F. Eberli, B. Meier, and T. Carrel Impact of clopidogrel in coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 96 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Nagarajan, P. S. Lewis, and J. Dunning Is clopidogrel beneficial following coronary bypass surgery? Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 311 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Bhatt Aspirin resistance: more than just a laboratory curiosity J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1127 - 1129. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Ringleb, D. L. Bhatt, A. T. Hirsch, E. J. Topol, W. Hacke, and for the CAPRIE Investigators Benefit of Clopidogrel Over Aspirin Is Amplified in Patients With a History of Ischemic Events Stroke, February 1, 2004; 35(2): 528 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Foody, F. D. Ferdinand, D. Galusha, S. S. Rathore, F. A. Masoudi, E. P. Havranek, D. Nilasena, M. J. Radford, and H. M. Krumholz Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction Circulation, September 9, 2003; 108(90101): II-24 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kurlansky Is there a hypercoagulable state after off-pump coronary artery bypass surgery? What do we know and what can we do? J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 7 - 10. [Full Text] [PDF]
|
|
|
|
|
|
H. Jneid, D. L. Bhatt, R. Corti, J. J. Badimon, V. Fuster, and G. S. Francis Aspirin and Clopidogrel in Acute Coronary Syndromes: Therapeutic Insights From the CURE Study Arch Intern Med, May 26, 2003; 163(10): 1145 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chaturvedi Should the Multicenter Carotid Endarterectomy Trials Be Repeated? Arch Neurol, May 1, 2003; 60(5): 774 - 775. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Hongo, J. Ley, S. E. Dick, and R. R. Yee The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting J. Am. Coll. Cardiol., July 17, 2002; 40(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Kapur and I S Malik Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease? Heart, May 1, 2002; 87(5): 407 - 409. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ehlers, T. W. Felbinger, H. K. Eltzschig, L. A. Fleisher, and K. A. Eagle Lowering Cardiac Risk in Noncardiac Surgery N. Engl. J. Med., April 4, 2002; 346(14): 1096 - 1097. [Full Text] [PDF]
|
|
|
|
|
|
M. Labinaz, R. Kilaru, K. Pieper, S. P. Marso, M. M. Kitt, M. L. Simoons, R. M. Califf, E. J. Topol, P. W. Armstrong, and R. A. Harrington Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Circulation, January 22, 2002; 105(3): 322 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bhatt, M. E. Bertrand, P. B. Berger, P. L. L'Allier, I. Moussa, J. W. Moses, G. Dangas, M. Taniuchi, J. M. Lasala, D. R. Holmes, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting J. Am. Coll. Cardiol., January 2, 2002; 39(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W.A. Verheugt, D. L. Bhatt, D. P. Chew, E. J. Topol, A. T. Hirsch, W. Hacke, and P. A. Ringleb Clopidogrel Versus Aspirin After Cardiac Surgery Response Circulation, September 25, 2001; 104 (13): e76 - e76. [Full Text] [PDF]
|
|
|
|
 |
|
 P. W Groeneveld and M. A Hlatky Clopidogrel reduced recurrent ischaemic events in patients with previous cardiac surgery more than aspirin Evid. Based Med., July 1, 2001; 6(4): 114 - 114. [Full Text] [PDF]
|
|
|
|
 |
|
 Clopidogrel Better Than Aspirin After Bypass Surgery Journal Watch Cardiology, April 6, 2001; 2001(406): 5 - 5. [Full Text]
|
|